Related Experiment Video
Updated: Jan 2, 2026
11:21
Bioinformatics Resources for the Study of Glycan-Mediated Protein Interactions
Published on: January 20, 2022
4.0K
Glycans in drug discovery.
Pablo Valverde1, Ana Ardá1, Niels-Christian Reichardt2
1CIC bioGUNE , Bizkaia Technology Park, Building 800 , 48162 Derio , Bizkaia , Spain .
Medchemcomm
|December 10, 2019
Summary
Carbohydrates, or glycans, are vital in biological processes and disease. Research highlights their potential in developing new therapeutics for infections, cancer, and immune disorders.
Area of Science:
- Biochemistry and Molecular Biology
- Glycoscience
- Drug Discovery
Background:
- Glycans play crucial roles in protein structure, stability, and cellular interactions.
- These biological roles make glycans significant targets for therapeutic intervention.
- Advancements in biophysical techniques enhance our understanding of glycan-mediated processes.
Purpose of the Study:
- To review the therapeutic potential of glycans in recurrent diseases.
- To highlight prominent contributions in glycan-based drug discovery.
- To explore strategies targeting glycan-mediated interactions.
Main Methods:
- Review of recent literature on glycan-related therapeutics.
- Analysis of strategies including glycomimetics, carbohydrate vaccines, and glycosylated antibodies.
- Focus on applications in infectious diseases, cancer, and immune pathologies.
Main Results:
- Glycomimetics show promise in blocking specific lectin-carbohydrate interactions.
- Carbohydrate-based vaccines are being developed to mimic antigens.
- Glycosylated antibodies offer therapeutic potential.
- Significant progress has been made in applying glycan knowledge to recurrent diseases.
Conclusions:
- Glycans represent a promising frontier in drug discovery for various diseases.
- Targeting glycan-mediated processes offers novel therapeutic avenues.
- Continued research in glycoscience is essential for developing effective treatments.
Related Concept Videos
01:26Drug Discovery: Overview
10.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K
01:25Protein Glycosylation
9.1K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
9.1K
01:14Glycocalyx and its Functions
7.6K
The glycocalyx is a carbohydrate-rich, fuzzy-appearing layer on the outer surface of the cell membrane. It is highly hydrophilic, because of this it attracts large amounts of water to the cell's surface. This aids the cell's interaction with the watery environment and also helps it to obtain substances dissolved in the water. It is also important for cell identification, self/non-self determination, and embryonic development and is used in cell-to-cell attachments to form tissues.
7.6K
01:05Proteoglycans
4.6K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.6K
01:24Oligosaccharide Assembly
3.5K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.5K
01:26Targets for Drug Action: Overview
9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K